Skip to main
CYRX

CryoPort (CYRX) Stock Forecast & Price Target

CryoPort (CYRX) Analyst Ratings

Based on 8 analyst ratings
Strong Buy
Strong Buy 63%
Buy 38%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

CryoPort is well-positioned to continue growing, with a strong focus on the emerging cell and gene therapy market. The company's global logistics network and partnerships with various commercial and clinical customers provide a strong platform for future revenue growth. Additionally, the company's cold storage and shipping technology, while impacted by the COVID-19 pandemic, is expected to continue growing in the coming years. These factors, combined with its high market share in the clinical trial market, make CryoPort a compelling investment opportunity.

Bears say

CryoPort is currently experiencing revenue growth and expects to see further expansion of revenue and margins through 2028. However, risks such as clinical trial success and macroeconomic pressures could negatively impact the company's growth. Additionally, the company's LT EBITDA margin target of ~30% may be too optimistic compared to its peers. Furthermore, while the company's current financial performance is strong, its valuation at ~14x FY28E EV/EBITDA is considered higher compared to its peers.

CryoPort (CYRX) has been analyzed by 8 analysts, with a consensus rating of Strong Buy. 63% of analysts recommend a Strong Buy, 38% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CryoPort and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CryoPort (CYRX) Forecast

Analysts have given CryoPort (CYRX) a Strong Buy based on their latest research and market trends.

According to 8 analysts, CryoPort (CYRX) has a Strong Buy consensus rating as of Jun 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $15.31, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $15.31, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CryoPort (CYRX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.